Get notified when HURA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: HURA TuHURA Biosciences, Inc./NV 8-K

TuHURA files updated pro forma financials for Kineta acquisition, approves executive raises

Filed April 8, 2026 · Period ending April 2, 2026 · ~1 min read

Key Changes

  • medium

    Company provides updated pro forma financials showing combined TuHURA-Kineta operations for full year 2025, as if the June 2025 acquisition had closed January 1. Gives clearer picture of merged entity's performance.

  • low

    CEO Dr. James Bianco received $490,536 bonus for 2025 performance and 5% salary increase to $605,956 annually, effective April 2, 2026.

  • low

    CFO Dan Dearborn received $163,393 bonus for 2025 performance and 5% salary increase to $403,676 annually, effective April 2, 2026.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade HURA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify